Export 611 results:
F
Couch, R.. B., Knight V.., Gerone P.. J., Cate T.. R., & Douglas R.. G. (1969).  Factors influencing response of volunteers to inoculation with Coxsackie virus A type 21. The American review of respiratory disease. 99, 1.
Yamamoto, H., Sugiura M., Kusunoki S., Ezaki T., Ikedo M., & Yabuuchi E. (1992).  Factors stimulating propagation of legionellae in cooling tower water. Applied and Environmental Microbiology. 58, 1394–1397.
Green, W.. R., Walker D.. H., & Cain B.. G. (1978).  Fatal viscerotropic Rocky Mountain spotted fever: report of a case diagnosed by immunofluorescence. (Med, A.. J., Ed.). 523-528.
Buck, A.. C., & Cooke E.. M. (1969).  The Fate Of Ingested Pseudomonas Aeruginosa In Normal Persons. Journal of Medical Microbiology. 2, 4.
Christy, C.., Madore H.. P., Pichichero M.. E., Gala C.., Pincus P.., Vosefski D.., et al. (1988).  Field trial of rhesus rotavirus vaccine in infants. The Pediatric infectious disease journal. 7, 9.
Lacey, RW. (1993).  Food-borne bacterial infections.
[Anonymous] (2012).  Foodborne Pathogenic Microorganisms and Natural Toxins Handbook Staphylococcus aureus.
NATICK, ILSC. (2016).   Force Provider.
Messner, MJ. (2014).  Fractional Poisson—A Simple Dose -Response Model for Human Norovirus. Risk Analysis.
Titball, R.. W., & Sjostedt A.. (2003).  Francisella tularensis: an overview. American Society for Microbiology News. 69, 558-563.
Thomas, V., McDonnell G., Denyer S. P., & Maillard J-Y. (2010).  Free-living amoebae and their intracellular pathogenic microorganisms: risks for water quality. FEMS microbiology reviews. 34, 231–259.
Cohen, B., Hyman S., Rosenberg L., & Larson E. (2012).  Frequency of patient contact with health care personnel and visitors: implications for infection prevention. The Joint Commission Journal on Quality and Patient Safety. 38, 560–565.
Aristizábal, H.., Acevedo J.., & M. B. (1991).  Fulminant amebic colitis. World J Surg.. 15,
Rose, J. B. (2000).  Future health assessment and risk-management integration for infectious diseases and biological weapons for deployed US forces. Strategies to Protect the Health of Deployed: Assessing Health Risks Deployed US Forces. 59–112.